Thomas Fischer Selected Research

Thomas Fischer Research Topics

Disease

35	Neoplasms (Cancer) 11/2022 - 12/2003
21	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 09/2021 - 04/2003
15	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 09/2021 - 01/2002
12	Prostatic Neoplasms (Prostate Cancer) 02/2022 - 09/2002
11	Leukemia 01/2019 - 01/2002
10	Pain (Aches) 10/2021 - 12/2004
7	Philadelphia Chromosome 10/2007 - 01/2002
6	Disease Progression 12/2020 - 03/2002
6	Lymphoma (Lymphomas) 01/2020 - 04/2005
5	Multiple Myeloma 11/2021 - 09/2015
5	Sepsis (Septicemia) 01/2019 - 08/2015
5	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2017 - 09/2002
5	Hematologic Neoplasms (Hematological Malignancy) 01/2017 - 08/2006
5	Blast Crisis (Blast Phase) 04/2007 - 05/2002
4	Hodgkin Disease (Hodgkin's Disease) 05/2016 - 07/2005
3	Heart Failure 01/2022 - 12/2008
3	Neoplasm Metastasis (Metastasis) 01/2022 - 12/2008
3	Inflammation (Inflammations) 01/2022 - 01/2021
3	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 06/2021 - 09/2014
3	Residual Neoplasm 01/2021 - 01/2002
3	Breast Neoplasms (Breast Cancer) 01/2021 - 03/2006
3	Dementia (Dementias) 03/2019 - 11/2012
3	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 10/2010 - 08/2006
2	Head and Neck Neoplasms (Head and Neck Cancer) 12/2022 - 01/2017
2	Polycythemia Vera 05/2022 - 01/2022
2	Venous Thrombosis (Deep-Vein Thrombosis) 03/2022 - 10/2018
2	Splenomegaly 01/2022 - 12/2021
2	Non-Hodgkin Lymphoma (Lymphosarcoma) 06/2021 - 12/2005
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 02/2021 - 01/2020
2	Infections 02/2021 - 09/2015
2	Delirium 01/2020 - 01/2019
2	Arthritis (Polyarthritis) 06/2019 - 09/2017
2	Thrombosis (Thrombus) 10/2018 - 11/2003
2	Blister (Bulla) 11/2017 - 08/2013
2	Carcinoma (Carcinomatosis) 08/2015 - 12/2008
2	Joint Diseases (Joint Disease) 03/2010 - 01/2006
2	Neuroblastoma 06/2009 - 02/2006
2	Hemorrhage 12/2004 - 11/2003
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 04/2022

Drug/Important Bio-Agent (IBA)

18	Imatinib Mesylate (Gleevec)FDA Link 02/2008 - 01/2002
10	Phosphotransferases (Kinase)IBA 04/2022 - 01/2005
8	Cytarabine (Cytosar-U)FDA LinkGeneric 12/2020 - 03/2003
7	Proteins (Proteins, Gene)FDA Link 12/2022 - 10/2002
7	Pharmaceutical PreparationsIBA 01/2021 - 05/2002
6	AntigensIBA 01/2022 - 08/2015
6	fms-Like Tyrosine Kinase 3IBA 01/2019 - 01/2005
6	Monoclonal AntibodiesIBA 11/2008 - 04/2005
6	bcr-abl Fusion ProteinsIBA 02/2008 - 02/2002
5	Rituximab (Mabthera)FDA Link 12/2019 - 04/2005
5	Prostate-Specific Antigen (Semenogelase)IBA 01/2019 - 09/2002
5	Tyrosine Kinase InhibitorsIBA 01/2018 - 04/2003
4	CytokinesIBA 03/2022 - 01/2017
3	DNA (Deoxyribonucleic Acid)IBA 04/2022 - 09/2009
3	Cisplatin (Platino)FDA LinkGeneric 01/2022 - 12/2010
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 12/2021 - 12/2014
3	Bortezomib (Velcade)FDA Link 11/2021 - 11/2017
3	Contrast MediaIBA 01/2021 - 03/2010
3	Dexamethasone (Maxidex)FDA LinkGeneric 11/2017 - 12/2010
3	Cyclophosphamide (Cytoxan)FDA LinkGeneric 11/2017 - 12/2005
3	Anti-Bacterial Agents (Antibiotics)IBA 09/2009 - 02/2005
3	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 11/2008 - 06/2006
3	Interferon-alpha (Interferon Alfa)IBA 02/2008 - 03/2003
2	Complement System Proteins (Complement)IBA 11/2022 - 09/2015
2	Type II Tumor Necrosis Factor ReceptorsIBA 05/2022 - 12/2021
2	Type I Tumor Necrosis Factor ReceptorsIBA 05/2022 - 12/2021
2	IntegrinsIBA 03/2022 - 10/2018
2	Transcription Factors (Transcription Factor)IBA 01/2022 - 01/2020
2	Interleukin-12 (IL 12)IBA 12/2021 - 01/2017
2	tyrosine receptor (receptor, tyrosine)IBA 09/2021 - 07/2007
2	Chemokine ReceptorsIBA 02/2021 - 01/2008
2	Analgesics (Analgesic Drugs)IBA 01/2020 - 03/2019
2	Matrix Metalloproteinases (MMPs)IBA 06/2019 - 03/2016
2	MicroRNAs (MicroRNA)IBA 01/2019 - 12/2008
2	Indicators and Reagents (Reagents)IBA 10/2016 - 02/2006
2	Vincristine (Oncovin)FDA LinkGeneric 08/2016 - 12/2005
2	Prednisone (Sone)FDA LinkGeneric 08/2016 - 12/2005
2	Doxorubicin (Adriamycin)FDA LinkGeneric 08/2016 - 12/2005
2	Radioisotopes (Radionuclides)IBA 01/2016 - 08/2015
2	midostaurinIBA 10/2010 - 01/2006
2	PanobinostatIBA 10/2009 - 08/2006
2	Neural Cell Adhesion Molecules (Neural Cell Adhesion Molecule)IBA 06/2009 - 02/2006
2	ParaffinIBA 11/2008 - 01/2008
2	Formaldehyde (Formol)FDA Link 11/2008 - 01/2008
2	FibrinIBA 11/2003 - 10/2002
1	AZD1390IBA 04/2022
1	2- (2,6- dimethylmorpholin- 4- yl)- N- (5- (6- morpholin- 4- yl- 4- oxo- 4H- pyran- 2- yl)- 9H- thioxanthen- 2- yl)acetamideIBA 04/2022

Therapy/Procedure

30	Therapeutics 02/2022 - 05/2002
16	Drug Therapy (Chemotherapy) 01/2022 - 04/2003
11	Stem Cell Transplantation 06/2021 - 01/2002
6	Radiotherapy 12/2022 - 03/2015
5	Central Venous Catheters 01/2019 - 08/2015
4	Home Nursing (Nursing, Home) 10/2021 - 10/2011
4	Aftercare (After-Treatment) 02/2021 - 10/2005
3	Immunotherapy 04/2022 - 04/2005
3	Pain Management 10/2021 - 05/2005
3	Homologous Transplantation 11/2019 - 01/2002
2	Prostatectomy (Retropubic Prostatectomy) 01/2017 - 04/2016
2	Intravenous Administration 10/2010 - 03/2010
2	Hematopoietic Stem Cell Transplantation 06/2007 - 09/2003
1	CT protocol 11/2022